Join our daily newsletter At The Bell to receive exclusive market insights
- LBT Innovations (LBT) has announced the first placement of APAS Independence in a U.K. lab
- The company’s APAS Independence has been installed and commissioned at the state-of-the-art Health Sciences Laboratory (HSL) in London
- HSL will evaluate the utility of APAS Independence and its potential to be integrated into its current solutions
- APAS Independence is a platform technology that automates and speeds up culture plate screening
- LBT is up 3.23 per cent on the market and shares are trading for 16 cents each
Meditech company LBT Innovations (LBT) has announced the first placement of APAS Independence in a U.K. lab.
The company’s APAS Independence has been installed and commissioned at the state-of-the-art Health Sciences Laboratory (HSL) in London.
The laboratory is a clinically led provider of pathology and diagnostic services and delivers innovation and value to the healthcare sector.
HSL will evaluate the utility of APAS Independence and its potential to be integrated into its current solutions.
Source: LBT Innovations
It will be installed alongside HSL’s current solutions and following initial training, and an evaluation will be carried out over a three-month period.
“We are extremely excited to be the first in the U.K. to trial the APAS Independence,” Head of Department, Infection Sciences at HSL Alan Spratt said.
“The application of assisted intelligence in a high-volume lab like ours has the potential to streamline laboratory workflows bringing benefits to staff, quality, turnaround times and consequentially patient outcomes,” he added.
APAS (Automated Plate Assessment System) Independence is a platform technology that automates culture plate screening and interpretation.
Thousands of culture plates are assessed everyday and currently each one has to be thoroughly examined. This can take time and may be subject to common human error.
APAS Independence speeds-up this process by automatically screening, interpreting and sorting the plates.
“Installation of the first APAS Independence in the U.K. represents another step forward in the commercialisation of the technology in Europe,” LBT CEO and Managing Director Brent Barnes commented.
“It was particularly pleasing to see the teams work closely together to complete the remote installation of the APAS instrument. This reflects the simple modular design of the technology and demonstrates how the company can continue to engage with customers whilst COVID-19 travel restrictions remain in place,” he added.
LBT is up 3.23 per cent on the market and shares are trading for 16 cents each at 12:25 pm AEST.
